Key Events This Week
4 May: Week opens at Rs.703.55
6 May: New 52-week high and all-time high reached near Rs.736 and Rs.732 respectively
8 May: Stock hits new 52-week and all-time high of Rs.756
8 May: Week closes at Rs.752.40, up 6.94%

Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 756
2026-05-08 10:35:46With a decisive break above Rs 750, Granules India Ltd has surged to a fresh 52-week high of Rs 756 on 8 May 2026, marking a remarkable 72.25% gain over the past year. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader Sensex trades lower by 0.41%.
Read full news article
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 736.6
2026-05-06 11:05:13Surging past its previous peaks, Granules India Ltd touched a new 52-week high of Rs 736.6 on 6 May 2026, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of robust technical indicators and sustained buying interest, setting the stage for a compelling momentum narrative.
Read full news articleGranules India Gains 1.47%: 4 Key Factors Driving the Week’s Momentum
2026-05-02 17:00:49
Key Events This Week
27 Apr: New 52-week high at Rs.699.4
29 Apr: New 52-week high at Rs.713.1 and all-time high at Rs.723
29 Apr: Q4 FY26 results announced with 32.59% profit growth
30 Apr: Week closes at Rs.699.25 (-0.90%)
Are Granules India Ltd latest results good or bad?
2026-04-29 19:14:42Granules India Ltd's latest financial results for Q4 FY26 reveal a strong operational performance characterized by significant growth in both revenue and net profit. The company reported net sales of ₹1,470.61 crores, reflecting a year-on-year increase of 22.81% and a quarter-on-quarter growth of 5.96%. This marks the highest quarterly revenue in the company's recent history, indicating robust demand across its product portfolio. Net profit for the quarter reached ₹201.57 crores, which represents a year-on-year increase of 32.59% and a quarter-on-quarter growth of 34.19%. The operating margin, excluding other income, expanded to 24.16%, up from 21.09% in the same quarter last year, showcasing enhanced operational efficiency and a favorable product mix. Granules India also demonstrated strong capital efficiency with a return on equity (ROE) of 15.81%, positioning it competitively within the pharmaceutical ...
Read full news article
Granules India Q4 FY26: Strong Finish with 32.59% Profit Growth Amid Margin Expansion
2026-04-29 17:45:35Granules India Ltd., a vertically integrated pharmaceutical manufacturer specialising in active pharmaceutical ingredients and finished dosages, delivered a robust fourth-quarter performance for FY26, with consolidated net profit surging 32.59% year-on-year to ₹201.57 crores. The Hyderabad-based company, commanding a market capitalisation of ₹17,625 crores, demonstrated strong operational momentum with sequential profit growth of 34.19% from Q3 FY26, whilst revenue expanded 22.81% year-on-year to ₹1,470.61 crores.
Read full news articleGranules India Limited - Analysts/Institutional Investor Meet/Con. Call Updates
09-Dec-2019 | Source : NSEGranules India Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
Granules India Limited - Analysts/Institutional Investor Meet/Con. Call Updates
13-Nov-2019 | Source : NSEGranules India Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
Granules India Limited - Record Date
23-Oct-2019 | Source : NSEGranules India Limited has informed the Exchange that the Company has fixed Record Date as November 2, 2019 for the purpose of For Payment of Second Interim Dividend for the FY 2019-20
Corporate Actions
No Upcoming Board Meetings
Granules India Ltd has declared 150% dividend, ex-date: 31 Jul 25
Granules India Ltd has announced 1:10 stock split, ex-date: 23 Mar 15
No Bonus history available
No Rights history available









